A carregar...
The use of PARP inhibitor - olaparib for the treatment of ovarian cancer in clinical practice
The treatment of patients with ovarian cancer remained unchanged over the past years: cytoreductive surgery and platinum-based chemotherapy regardless of the histological type of the tumor. A deeper understanding of ovarian cancer biology has paved the way to developing targeted drugs; the most stud...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
IP Habib O.N.
2016-12-01
|
| Colecção: | Современная онкология |
| Assuntos: | |
| Acesso em linha: | https://modernonco.orscience.ru/1815-1434/article/viewFile/27078/pdf |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|